147 related articles for article (PubMed ID: 16299162)
1. Development of novel furanocoumarin dimers as potent and selective inhibitors of CYP3A4.
Row E; Brown SA; Stachulski AV; Lennard MS
Drug Metab Dispos; 2006 Feb; 34(2):324-30. PubMed ID: 16299162
[TBL] [Abstract][Full Text] [Related]
2. Inhibition selectivity of grapefruit juice components on human cytochromes P450.
Tassaneeyakul W; Guo LQ; Fukuda K; Ohta T; Yamazoe Y
Arch Biochem Biophys; 2000 Jun; 378(2):356-63. PubMed ID: 10860553
[TBL] [Abstract][Full Text] [Related]
3. Synthetic models related to furanocoumarin-CYP 3A4 interactions. comparison of furanocoumarin, coumarin, and benzofuran dimers as potent inhibitors of CYP3A4 activity.
Oda K; Yamaguchi Y; Yoshimura T; Wada K; Nishizono N
Chem Pharm Bull (Tokyo); 2007 Sep; 55(9):1419-21. PubMed ID: 17827777
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and evaluation of furanocoumarin monomers as inhibitors of CYP3A4.
Row EC; Brown SA; Stachulski AV; Lennard MS
Org Biomol Chem; 2006 Apr; 4(8):1604-10. PubMed ID: 16604230
[TBL] [Abstract][Full Text] [Related]
5. Dihydroxybergamottin caproate as a potent and stable CYP3A4 inhibitor.
Ohta T; Nagahashi M; Hosoi S; Tsukamoto S
Bioorg Med Chem; 2002 Apr; 10(4):969-73. PubMed ID: 11836106
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins.
Schmiedlin-Ren P; Edwards DJ; Fitzsimmons ME; He K; Lown KS; Woster PM; Rahman A; Thummel KE; Fisher JM; Hollenberg PF; Watkins PB
Drug Metab Dispos; 1997 Nov; 25(11):1228-33. PubMed ID: 9351897
[TBL] [Abstract][Full Text] [Related]
7. Potent inhibition of human cytochrome P450 3A4, 2D6, and 2C9 isoenzymes by grapefruit juice and its furocoumarins.
Girennavar B; Jayaprakasha GK; Patil BS
J Food Sci; 2007 Oct; 72(8):C417-21. PubMed ID: 17995595
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of 8-geranyloxypsoralen analogues and their evaluation as inhibitors of CYP3A4.
Row EC; Brown SA; Stachulski AV; Lennard MS
Bioorg Med Chem; 2006 Jun; 14(11):3865-71. PubMed ID: 16481174
[TBL] [Abstract][Full Text] [Related]
9. [Synthesis of Furanocoumarin, Benzofuran and Coumarin Derivatives Possessing an Inhibitory Effect on Human CYP, and Elucidation of the Inhibitory Mechanism].
Yamaguchi Y
Yakugaku Zasshi; 2017; 137(10):1209-1214. PubMed ID: 28966261
[TBL] [Abstract][Full Text] [Related]
10. Automated screening with confirmation of mechanism-based inactivation of CYP3A4, CYP2C9, CYP2C19, CYP2D6, and CYP1A2 in pooled human liver microsomes.
Lim HK; Duczak N; Brougham L; Elliot M; Patel K; Chan K
Drug Metab Dispos; 2005 Aug; 33(8):1211-9. PubMed ID: 15860655
[TBL] [Abstract][Full Text] [Related]
11. Fully automated analysis of activities catalysed by the major human liver cytochrome P450 (CYP) enzymes: assessment of human CYP inhibition potential.
Moody GC; Griffin SJ; Mather AN; McGinnity DF; Riley RJ
Xenobiotica; 1999 Jan; 29(1):53-75. PubMed ID: 10078840
[TBL] [Abstract][Full Text] [Related]
12. Gemfibrozil is a potent inhibitor of human cytochrome P450 2C9.
Wen X; Wang JS; Backman JT; Kivistö KT; Neuvonen PJ
Drug Metab Dispos; 2001 Nov; 29(11):1359-61. PubMed ID: 11602509
[TBL] [Abstract][Full Text] [Related]
13. N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine (DPPE) a chemopotentiating and cytoprotective agent in clinical trials: interaction with histamine at cytochrome P450 3A4 and other isozymes that metabolize antineoplastic drugs.
Brandes LJ; Queen GM; LaBella FS
Cancer Chemother Pharmacol; 2000; 45(4):298-304. PubMed ID: 10755318
[TBL] [Abstract][Full Text] [Related]
14. Further assessment of 17alpha-ethinyl estradiol as an inhibitor of different human cytochrome P450 forms in vitro.
Chang SY; Chen C; Yang Z; Rodrigues AD
Drug Metab Dispos; 2009 Aug; 37(8):1667-75. PubMed ID: 19454483
[TBL] [Abstract][Full Text] [Related]
15. Effect of furanocoumarin derivatives in grapefruit juice on the uptake of vinblastine by Caco-2 cells and on the activity of cytochrome P450 3A4.
Ohnishi A; Matsuo H; Yamada S; Takanaga H; Morimoto S; Shoyama Y; Ohtani H; Sawada Y
Br J Pharmacol; 2000 Jul; 130(6):1369-77. PubMed ID: 10903978
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of gypenosides on seven human cytochrome P450 enzymes in vitro.
He M; Jiang J; Qiu F; Liu S; Peng P; Gao C; Miao P
Food Chem Toxicol; 2013 Jul; 57():262-5. PubMed ID: 23583485
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of glyburide on human cytochrome p450 isoforms in human liver microsomes.
Kim KA; Park JY
Drug Metab Dispos; 2003 Sep; 31(9):1090-2. PubMed ID: 12920163
[TBL] [Abstract][Full Text] [Related]
18. Specific CYP3A4 inhibitors in grapefruit juice: furocoumarin dimers as components of drug interaction.
Fukuda K; Ohta T; Oshima Y; Ohashi N; Yoshikawa M; Yamazoe Y
Pharmacogenetics; 1997 Oct; 7(5):391-6. PubMed ID: 9352575
[TBL] [Abstract][Full Text] [Related]
19. Pioglitazone is metabolised by CYP2C8 and CYP3A4 in vitro: potential for interactions with CYP2C8 inhibitors.
Jaakkola T; Laitila J; Neuvonen PJ; Backman JT
Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):44-51. PubMed ID: 16867170
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of memantine on human cytochrome P450 activities: prediction of in vivo drug interactions.
Micuda S; Mundlova L; Anzenbacherova E; Anzenbacher P; Chladek J; Fuksa L; Martinkova J
Eur J Clin Pharmacol; 2004 Oct; 60(8):583-9. PubMed ID: 15378224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
